Paul Von Autenried Bristol Myers Squibb CO (BMY) insider trading activity

Paul Von Autenried is EVP, Chief Information Officer of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 0 shares of BMY, which is worth approximately $0. The most recent transaction as insider was on Jul 30, 2021, when has been sold 114,670 shares (Common Stock, $0.10 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Paul von Autenried Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 30 2021	SELL Bona fide gift	-	114,670 Reduced 100.0%	0 Common Stock, $0.10 pa...
Jul 30 2021	SELL Open market or private sale	$1,701,500 $68.06 p/Share	25,000 Reduced 17.9%	114,670 Common Stock, $0.10 pa...
Mar 10 2021	SELL Other acquisition or disposition	-	167 Reduced 0.13%	129,952 Common Stock, $0.10 pa...
Mar 10 2021	SELL Payment of exercise price or tax liability	$610,336 $60.93 p/Share	10,017 Reduced 6.69%	139,670 Common Stock, $0.10 pa...
Mar 10 2021	BUY Other acquisition or disposition	-	2,854 Added 1.92%	146,039 Common Stock, $0.10 pa...
Mar 10 2021	BUY Exercise of conversion of derivative security	-	20,302 Added 12.37%	143,800 Common Stock, $0.10 pa...
Nov 25 2020	SELL Open market or private sale	$190 $63.5 p/Share	3 Reduced 0.0%	126,698 Common Stock, $0.10 pa...
Nov 24 2020	SELL Open market or private sale	$1,255,000 $62.75 p/Share	20,000 Reduced 13.63%	126,701 Common Stock, $0.10 pa...
Mar 10 2020	SELL Payment of exercise price or tax liability	$622,052 $57.93 p/Share	10,738 Reduced 6.82%	146,701 Common Stock, $0.10 pa...
Mar 10 2020	SELL Other acquisition or disposition	-	124 Reduced 0.09%	139,268 Common Stock, $0.10 pa...
Mar 10 2020	BUY Other acquisition or disposition	-	2,030 Added 1.3%	153,636 Common Stock, $0.10 pa...
Mar 10 2020	BUY Exercise of conversion of derivative security	-	20,806 Added 12.01%	152,400 Common Stock, $0.10 pa...
Mar 10 2019	SELL Other acquisition or disposition	-	1,506 Reduced 1.15%	129,763 Common Stock, $0.10 pa...
Mar 10 2019	SELL Payment of exercise price or tax liability	$460,249 $51.39 p/Share	8,956 Reduced 6.23%	134,727 Common Stock, $0.10 pa...
Mar 10 2019	BUY Exercise of conversion of derivative security	-	19,925 Added 12.38%	141,077 Common Stock, $0.10 pa...
Mar 10 2018	SELL Payment of exercise price or tax liability	$1,015,676 $67.92 p/Share	14,954 Reduced 10.66%	125,264 Common Stock, $0.10 pa...
Mar 10 2018	BUY Exercise of conversion of derivative security	-	31,275 Added 18.65%	136,441 Common Stock, $0.10 pa...
Mar 10 2018	BUY Other acquisition or disposition	-	1,134 Added 0.98%	114,940 Common Stock, $0.10 pa...
Mar 10 2017	SELL Other acquisition or disposition	-	557 Reduced 0.56%	98,064 Common Stock, $0.10 pa...
Mar 10 2017	SELL Payment of exercise price or tax liability	$904,018 $58.32 p/Share	15,501 Reduced 12.54%	108,130 Common Stock, $0.10 pa...
Mar 10 2017	BUY Other acquisition or disposition	-	1,362 Added 1.4%	96,158 Common Stock, $0.10 pa...
Mar 10 2017	BUY Exercise of conversion of derivative security	-	31,721 Added 20.94%	119,772 Common Stock, $0.10 pa...
May 02 2016	SELL Open market or private sale	$2,679,968 $71.93 p/Share	37,258 Reduced 29.0%	91,205 Common Stock, $0.10 pa...
May 02 2016	BUY Exercise of conversion of derivative security	$901,835 $17.51 p/Share	51,504 Added 28.62%	128,463 Common Stock, $0.10 pa...
Mar 10 2016	SELL Other acquisition or disposition	-	32 Reduced 0.05%	66,383 Common Stock, $0.10 pa...

Also insider at

SNCE

Science 37 Holdings, Inc. Healthcare

PvA